US Bancorp
COLL icon

US Bancorp’s Collegium Pharmaceutical COLL Stock Holding History

US Bancorp’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.54K Buy
236
+57
+32% +$1.95K ﹤0.01% 3508
2026
Q1 		$5.92K Hold
179
– – ﹤0.01% 3522
2025
Q4 		$8.29K Sell
179
-53
-23% -$2.22K ﹤0.01% 3391
2025
Q3 		$8.12K Sell
232
-162
-41% -$5.63K ﹤0.01% 3382
2025
Q2 		$11.7K Buy
394
+167
+74% +$4.76K ﹤0.01% 3376
2025
Q1 		$6.78K Buy
227
+65
+40% +$1.99K ﹤0.01% 3563
2024
Q4 		$4.64K Hold
162
– – ﹤0.01% 3667
2024
Q3 		$6.26K Hold
162
– – ﹤0.01% 3507
2024
Q2 		$5.22K Buy
162
+4
+3% +$139 ﹤0.01% 3499
2024
Q1 		$6.13K Buy
+158
New +$5.53K ﹤0.01% 3478
2023
Q3 		– Sell
-75
Closed -$1.61K – 4010
2023
Q2 		$1.61K Sell
75
-9
-11% -$204 ﹤0.01% 3733
2023
Q1 		$2.02K Buy
84
+9
+12% +$239 ﹤0.01% 3753
2022
Q4 		$1.74K Hold
75
– – ﹤0.01% 3810
2022
Q3 		$1K Hold
75
– – ﹤0.01% 3928
2022
Q2 		$1K Sell
75
-318
-81% -$5.35K ﹤0.01% 3934
2022
Q1 		$8K Buy
+393
New +$7.42K ﹤0.01% 3442
2021
Q3 		– Sell
-31
Closed -$1K – 4092
2021
Q2 		$1K Buy
+31
New +$716 ﹤0.01% 3896
2019
Q1 		– Sell
-2,449
Closed -$42K – 3581
2018
Q4 		$42K Hold
2,449
– – ﹤0.01% 2529
2018
Q3 		$36K Hold
2,449
– – ﹤0.01% 2715
2018
Q2 		$58K Hold
2,449
– – ﹤0.01% 2502
2018
Q1 		$63K Hold
2,449
– – ﹤0.01% 2473
2017
Q4 		$45K Buy
+2,449
New +$35.1K ﹤0.01% 2640

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

US Bancorp's COLL Position: Q2 2026 in Review

US Bancorp increased its Collegium Pharmaceutical (COLL) stake by 32% in Q2 2026, buying an estimated $1.95K and bringing the position to 236 shares worth $8.54K. The position accounts for ﹤0.01% of the portfolio, ranked #3508.

US Bancorp first reported a position in COLL in Q4 2017 and has held it in 22 quarters since. The position peaked at $63K in Q1 2018. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • US Bancorp held 236 shares of Collegium Pharmaceutical worth $8.54K as of Q2 2026.
  • US Bancorp bought 57 Collegium Pharmaceutical shares in Q2 2026, an estimated $1.95K.
  • Collegium Pharmaceutical made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3508 holding.
  • US Bancorp first reported a position in Collegium Pharmaceutical in Q4 2017 and has held it in 22 quarters since.
  • US Bancorp's Collegium Pharmaceutical position peaked at $63K in Q1 2018.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.